Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: results of the RAPID-PsA 24-week phase III double-blind randomised placebo-controlled study of certolizumab pegol-Reference-Cited by-同舟云学术

Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: results of the RAPID-PsA 24-week phase III double-blind randomised placebo-controlled study of certolizumab pegol

Published:2013-08-13 Issue:1 Volume:73 Page:233-237
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

van der Heijde D,Fleischmann R,Wollenhaupt J,Deodhar A,Kielar D,Woltering F,Stach C,Hoepken B,Arledge T,Mease P J

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference13 articles.

1. Use of imaging as an outcome measure in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis in clinical trials;Van Der Heijde,2011

2. Golimumab, a new human tumor necrosis factor α antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: twenty-four–week efficacy and safety results of a randomized, placebo-controlled study;Kavanaugh;Arthritis Rheum,2009

3. Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial;Mease;Arthritis Rheum,2005

4. The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year;Kavanaugh;Ann Rheum Dis,2006

5. Golimumab in psoriatic arthritis: one-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial;Kavanaugh;Arthritis Rheum,2012

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rab4A-directed endosome traffic shapes pro-inflammatory mitochondrial metabolism in T cells via mitophagy, CD98 expression, and kynurenine-sensitive mTOR activation;Nature Communications;2024-03-22

2. Comment on ‘Effects of Vivifrail multicomponent intervention on functional capacity: A multicentre randomized controlled trial’ by Casas‐Herrero et al.;Journal of Cachexia, Sarcopenia and Muscle;2023-08-30

3. English version of Japanese guidance for use of biologics for psoriasis (the 2022 version);The Journal of Dermatology;2022-12-29

4. Current and emerging biologic and small molecule systemic treatment options for psoriasis and psoriatic arthritis;Current Opinion in Pharmacology;2022-12

5. Pharmacoeconomic aspects of the targeted drugs use in psoriatic arthritis in context of the Russian healthcare system;Modern Rheumatology Journal;2022-10-18